Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC

Niu, MK; Yi, M; Li, N; Luo, SX; Wu, KM

Luo, SX; Wu, KM (corresponding author), Zhengzhou Univ, Affiliated Canc Hosp, Dept Med Oncol, Zhengzhou 450008, Peoples R China.; Luo, SX; Wu, KM (corresponding author), Henan Canc Hosp, Zhengzhou 450008, Peoples R China.

EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2021; 10 (1):

Abstract

Immunotherapy, especially anti-programmed cell death protein 1/programmed cell death ligand 1 (PD-1/PD-L1) treatment has significantly improved the su......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索